Desipramine Terminated Phase 2 Trials for Lung Cancer Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01719861Phase IIa Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors